- freely available
- re-usable
Int. J. Mol. Sci. 2008, 9(6), 1096-1107; doi:10.3390/ijms9061096
Review
Betulinic Acid for Cancer Treatment and Prevention
University Children’s Hospital, Eythstr. 24, 89075 Ulm, Germany
Published: 27 June 2008
(This article belongs to the Special Issue Natural Compounds for Cancer Treatment and Prevention)
Abstract: Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of betulinic acid against a variety of cancer types, normal cells and tissue are relatively resistant to betulinic acid, pointing to a therapeutic window. Compounds that exert a direct action on mitochondria present promising experimental cancer therapeutics, since they may trigger cell death under circumstances in which standard chemotherapeutics fail. Thus, mitochondrion-targeted agents such as betulinic acid hold great promise as a novel therapeutic strategy in the treatment of human cancers.
Keywords: apoptosis; cancer; betulinic acid; mitochondria
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Fulda, S. Betulinic Acid for Cancer Treatment and Prevention. Int. J. Mol. Sci. 2008, 9, 1096-1107.
AMA StyleFulda S. Betulinic Acid for Cancer Treatment and Prevention. International Journal of Molecular Sciences. 2008; 9(6):1096-1107.
Chicago/Turabian StyleFulda, Simone. 2008. "Betulinic Acid for Cancer Treatment and Prevention." Int. J. Mol. Sci. 9, no. 6: 1096-1107.
Int. J. Mol. Sci.
EISSN 1422-0067
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
